Glenzocimab Antibody

• Catalog Number: orb1944777
• Category: Antibodies
• Description: Glenzocimab (ACT017), a Fab fragment of a humanized anti-GPVI monoclonal antibody, demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model and has been studied in acute ischemic stroke and cerebral thrombosis.
• Clonality: Monoclonal
• CAS Number: 2101829-58-5
• Concentration: 4.9 mg/mL
• Purity: > 95%
• Conjugation: Unconjugated
• MW: 48.29 kDa
• Target: Glenzocimab
• Biological Activity: Glenzocimab (ACT017) is a Fab fragment of a humanized anti-GPVI monoclonal antibody. Glenzocimab demonstrated inhibition of collagen-induced platelet aggregation in an ischemic stroke model. Glenzocimab has been studied in acute ischemic stroke and cerebral thrombosis.
• Storage: Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
• Note: For research use only
• Expiration Date: 12 months from date of receipt.